Harold Edward Smith, M.D.; Revocation Of Registration, 53961-53964 [2011-22090]
Download as PDF
Federal Register / Vol. 76, No. 168 / Tuesday, August 30, 2011 / Notices
I conclude that Respondent’s
registration with the DEA would be
inconsistent with the public interest.
Dated: August 16, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Recommended Decision
[FR Doc. 2011–22088 Filed 8–29–11; 8:45 am]
Conclusion
I recommend that Respondent’s
controlled substances registration be
revoked and his application for renewal
and modification of his DEA registration
be denied.
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Dated: June 15, 2010.
Mary Ellen Bittner,
Administrative Law Judge.
Manufacturer of Controlled
Substances; Notice of Registration
[FR Doc. 2011–22093 Filed 8–29–11; 8:45 am]
By Notice dated April 15, 2011, and
published in the Federal Register on
April 27, 2011, 76 FR 23627, Cedarburg
Pharmaceuticals, Inc., 870 Badger
Circle, Grafton, Wisconsin 53024, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
4–Anilino-N-phenethyl-4–Piperidine
(8333), a basic class of controlled
substance listed in schedule II.
The company plans to use this
controlled substance in the
manufacturer of another controlled
substance.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a), and
determined that the registration of
Cedarburg Pharmaceuticals, Inc., to
manufacture the listed basic class of
controlled substance is consistent with
the public interest at this time. DEA has
investigated Cedarburg Pharmaceuticals,
Inc., to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
mstockstill on DSK4VPTVN1PROD with NOTICES
Importer of Controlled Substances;
Notice of Registration
By Notice dated June 7, 2011, and
published in the Federal Register on
June 16, 2011, 76 FR 35241, Wildlife
Laboratories, 1401 Duff Drive, Suite 400,
Fort Collins, Colorado 80524, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of
Etorphine Hydrochloride (9059), a basic
class of controlled substance listed in
schedule II.
The company plans to import the
listed controlled substance for sale to its
customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Wildlife Laboratories to import the basic
class of controlled substance is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Wildlife Laboratories to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
VerDate Mar<15>2010
20:31 Aug 29, 2011
Jkt 223001
Dated: August 16, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–22089 Filed 8–29–11; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
53961
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Harold Edward Smith, M.D.;
Revocation Of Registration
On April 17, 2009, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, issued an Order to
Show Cause to Harold Edward Smith,
M.D. (Respondent), of Mt. Dora, Florida.
The Show Cause Order proposed the
revocation of Respondent’s DEA
Certificate of Registration, BS4681979,
and the denial of any pending
applications to renew or modify the
registration, on the grounds that
Respondent had materially falsified
various applications for his DEA
registration and had committed acts
which render his registration
inconsistent with the public interest.
Show Cause Order at 1 (citing 21 U.S.C.
824(a)(1) & (4)).
The Show Cause Order alleged that
Respondent has ‘‘a documented
substance abuse history dating back as
far as 1982,’’ when he ‘‘entered
treatment for alcohol and controlled
substance abuse.’’ Id. The Order alleged
that on April 3, 1985, Respondent
entered into a consent order with the
Georgia Board of Medical Examiners
(Georgia Board) based on his ‘‘chemical
dependency,’’ which placed him on
probation for four years and imposed
various conditions including that he
‘‘abstain from the consumption of
alcohol or controlled substances,’’
undergo random drug testing, and
‘‘relinquish’’ his controlled substance
privileges. Id. The Order then alleged
that in June 1990, Respondent tested
positive for cocaine and that on October
10, 1990, he ‘‘entered into an Interim
Consent Order’’ with the Georgia Board
under which his medical license was
suspended and he was ordered (1) Not
to practice medicine, (2) not to use his
DEA registration, and (3) ‘‘to participate
in a program for impaired physicians.’’
Id. at 2.
Next, the Show Cause Order alleged
that during 1999 and 2000, Respondent
issued prescriptions for hydrocodone to
J.R.S. and L.L.S., and had failed to
maintain the ‘‘records of any
examinations, diagnoses, treatment[s] or
* * * drugs prescribed to these
individuals as required by Section
458.331(1)(q) of the Florida statutes.’’ Id.
The Order further alleged that based on
this conduct, Respondent ‘‘entered into
a Consent Agreement with the’’ Florida
Board of Medicine, which required him
to pay a fine of $5,000, desist ‘‘from
prescribing to family members’’ and to
E:\FR\FM\30AUN1.SGM
30AUN1
53962
Federal Register / Vol. 76, No. 168 / Tuesday, August 30, 2011 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
take ‘‘a course on the proper prescribing
of [a]busable [d]rugs.’’ Id. (int.
quotations omitted).
The Show Cause Order further alleged
that on February 16, 2007, the Florida
Board indefinitely suspended
Respondent’s medical license ‘‘based in
part’’ on his ‘‘admission of’’ having
‘‘relapse[d] on crack cocaine’’ and
‘‘failure to submit to a urine screen
while under contract with the Board’s
impaired physicians’ program.’’ Id. The
Order then alleged that on June 26,
2007, the Florida Board reinstated
Respondent’s medical license ‘‘subject
to several probationary terms.’’ Id.
Finally, the Show Cause Order alleged
that ‘‘[o]n April 22, 2002, February 28,
2005, and again on January 31, 2008,’’
Respondent had ‘‘submitted
applications for renewal’’ of his DEA
registration. Id. The Order alleged that
each of these applications was
materially false because Respondent
failed to disclose the various sanctions
imposed on his state licenses by the
Georgia and Florida Boards, as well as
the previous ‘‘surrenders’’ of his DEA
registration. Id.
On May 8, 2009, the Show Cause
Order, which also notified Respondent
of his right to request a hearing on the
allegations (or to submit a written
statement in lieu of a hearing) and the
consequences if he failed to do so, Id.
at 2, was served on Respondent by
certified mail to him at the address
given on his most recent application as
his registered location. Since that date,
neither Respondent, nor any person
purporting to represent him, has filed a
request for a hearing or submitted a
written statement in lieu of a hearing.
As thirty days have now passed since
Respondent was served with the Order
to Show Cause, I find that Respondent
has waived his right to a hearing. See 21
CFR 1301.43(d). I therefore enter this
Final Order without a hearing based on
relevant evidence contained in the
Investigative Record. See Id. at
1301.43(e). I make the following
findings.
Findings
Respondent currently holds DEA
Certificate of Registration BS4681979,
which authorizes him to dispense
controlled substances in schedules II
through V as a practitioner, at the
registered address of 2875 S. Orange
Ave., Suite 500–600, Orlando, Florida.
While Respondent’s registration was to
expire on February 29, 2008, on
February 7, 2008, he submitted an
application to renew his registration. In
accordance with the Administrative
Procedure Act, Respondent’s
registration remains in effect pending
VerDate Mar<15>2010
20:31 Aug 29, 2011
Jkt 223001
the issuance of this Final Order. See 5
U.S.C. 558(c).
The State Proceedings Against
Respondent
In April 1983, Respondent, who was
then licensed in Arkansas and
Tennessee, was discharged from an
impaired physicians program.
Thereafter, Respondent applied for a
Georgia medical license. On April 17,
1985, Respondent entered into a
Consent Order with the Georgia Board,
which noted that he had ‘‘completed a
treatment program for chemical
dependency.’’ Consent Order at 1, In re
Harold Edward Smith, Jr., M.D., No.
91328–85 (Ga. Bd. Med. Exam’rs, April
17, 1985). Pursuant to the Consent
Order, the Georgia Board issued
Respondent a medical license and
placed him on probation for four years
subject to several conditions. Id. at 2–4.
The conditions included that he
‘‘completely abstain from the
consumption of alcohol or controlled
substances, except as prescribed by a
duly licensed practitioner for a
legitimate purpose,’’ that he ‘‘undergo
random alcohol/drug screening at his
own expense,’’ that he ‘‘not possess a
DEA permit or any triplicate
prescription forms or Federal order
forms,’’ and that he relinquish his right
(until further order by the Board) ‘‘to
prescribe, administer, dispense, order or
possess (except as prescribed,
administered or dispensed to [him] by
another person authorized by law to do
so) controlled substances.’’ Id.
Respondent was also required to
‘‘submit quarterly reports regarding his
physical and mental condition to the
Board * * * including a report on any
medication being prescribed to’’ him. Id.
at 3. In April 1989, Respondent was
‘‘discharged from probation.’’ Interim
Consent Order for Suspension of
License During Treatment at 1, In re
Harold Edward Smith, Jr., M.D., No. 90–
499 (Ga. Bd. Med. Exam’rs, Oct. 10,
1990).
In June 1990, physicians at
Respondent’s place of employment
requested that he provide a specimen
for drug testing. Id. at 2. The specimen
tested positive for cocaine. Id.
Subsequently, the Georgia Board
ordered Respondent to ‘‘undergo a 72hour inpatient mental/physical
examination evaluation’’ and thereafter,
Respondent entered ‘‘treatment for
relapse of chemical dependence.’’ Id.
On October 10, 1990, Respondent
entered into an Interim Consent Order
with the Georgia Board pursuant to
which he agreed that his license would
be ‘‘suspended until further order of the
board’’; that during the suspension, he
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
would ‘‘not engage in the practice of
medicine or be authorized to utilize his
DEA registration for controlled
substances’’; and that he would not
resume practicing medicine or use his
DEA registration ‘‘without the prior
written approval of the Board.’’ Id. at 3
& 8. Respondent also agreed to ‘‘remain
in treatment,’’ to ‘‘abide by all
conditions of his treatment/aftercare
program,’’ and to submit ‘‘quarterly
reports on his mental/physical
condition and progress in
rehabilitation.’’ Id. at 3. Moreover, as a
condition of the Board’s lifting of the
suspension (after he completed
treatment and executed an aftercare
contract), Respondent was required to
submit: (1) A certification by his
monitoring physicians that he had
‘‘successfully completed treatment’’ and
‘‘is able to resume the practice of
medicine with reasonable skill and
safety,’’ (2) a plan to return to practice
under a ‘‘physician who would actively
supervise [his] practice,’’ and (3) ‘‘a
summary of continuing education
activity in the last year.’’ Id. at 4–5.
At some point, Respondent moved to
Florida and obtained a medical license
from the Florida Department of Health
(DOH). On October 18, 2002, the DOH
filed an Administrative Complaint
against him. See Administrative
Complaint, Department of Health v.
Smith, No. 2000–12434 (Fla. DOH). The
Complaint alleged that ‘‘[f]rom on or
about July 24, 1999 to on or about
August 14, 2000,’’ Respondent wrote
hydrocodone prescriptions for J.R.S.,
and that ‘‘[f]rom on or about January 14,
2000 to on or about June 30, 2000,’’
Respondent wrote hydrocodone
prescription for L.L.S., both of whom
were alleged to be related to him. Id. at
2. The Complaint further alleged that
Respondent ‘‘did not keep records of
[his] examinations, diagnoses, treatment
or * * * drugs prescribed’’ for either
person. Id.
On June 18, 2003, Respondent entered
into a Consent Agreement with the
DOH. Consent Agreement at 6–7.
Therein, Respondent neither admitted
nor denied the allegations. Id. at 2.
However, he agreed to pay a fine of
$2,000, to reimburse the DOH for its
costs in the amount of $4,776.58, and to
complete a course entitled ‘‘Protecting
Your Medical Practice, Clinical, Legal
and Ethical Issues in Prescribing
Abusable Drugs.1 ’’ Id. at 2–4.
On August 18, 2003, the Florida
Board of Medicine rejected the Consent
1 The Order further noted that ‘‘[t]he terminal
condition of Respondent’s mother understandably
contributed to poor judgment for the time he
provided prescriptions for her.’’ Consent Agreement
at 4.
E:\FR\FM\30AUN1.SGM
30AUN1
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 76, No. 168 / Tuesday, August 30, 2011 / Notices
Agreement and offered a counter
agreement, which the parties accepted.
Final Order at 1. The Agreement
increased the fine to $5,000, imposed a
restriction on his license requiring him
to ‘‘remain in compliance with any and
all terms of’’ his contract with the
Professional Resource Network (PRN),
and prohibited him ‘‘from writing
prescriptions for controlled substances
for any family member.’’ Id. at 1–2.
On May 31, 2006, the DOH filed
another Administrative Complaint
against Respondent. Administrative
Complaint, Department of Health v.
Harold Smith, M.D., No. 2005–67946.
The Complaint alleged that on
approximately August 9, 2005,
Respondent had ceased complying with
his PRN contract and that, on August
16, 2005, a PRN monitor had contact
with him and ‘‘recommended,’’ based
on his ‘‘body language and general
demeanor[,] * * * that [he] undergo a
psychiatric evaluation.’’ Id. at 4–5. PRN
then allegedly ‘‘requested that
Respondent submit to a psychiatric
evaluation and drug screen’’; however,
Respondent failed to ‘‘present for his
drug screen.’’ Id. at 5. The Complaint
further alleged that three weeks later,
‘‘Respondent contacted PRN and
admitted to a relapse on crack cocaine
and agreed to be evaluated.’’ Id.
The Complaint alleged that on or
about October 7, 2005, Respondent was
evaluated and ‘‘diagnosed with cocaine
dependence’’ and ‘‘opioid dependence,
in apparent relapse.’’ Id. The Complaint
further alleged that the evaluator found
that ‘‘Respondent was not safe to
practice medicine’’ and recommended
that he enter a ‘‘structured
detoxification and stabilization unit and
undergo intensive psychotherapy.’’ Id.
at 5–6. The Complaint alleged that
while Respondent completed this
portion of his treatment, he
subsequently refused to enter into a
halfway house, did not have a phone,
and had no money to pay for urine
screens. Id. at 6. The State thus alleged
that Respondent was ‘‘unable to practice
medicine with reasonable skill and
safety to patients due to his substance
abuse problems and his unwillingness
to undergo additional treatment’’ and
monitoring by PRN. Id. at 7.
In February 2007, the Florida Board of
Medicine issued a Final Order adopting
a settlement agreement which
Respondent had entered into with the
State. Final Order at 2, DOH v. Harold
Smith, M.D., No. 2005–67946 (Fla. Bd.
Med., Feb. 15, 2007). Apparently (as the
agreement is not part of the record),
Respondent had agreed to the
suspension of his medical license. See
Order on Reinstatement, DOH v. Harold
VerDate Mar<15>2010
20:31 Aug 29, 2011
Jkt 223001
Smith, M.D., No. 2005–67946 (Fla. Bd.
Med., June 26, 2007).
On June 26, 2007, the Board
reinstated Respondent’s license and
placed him ‘‘on probation for a period
to run concurrent with his [PRN]
contract.’’ Id. at 1. The Board imposed
the following conditions: That he
comply with his PRN contract; that he
appear before the Board’s ‘‘Probationer’s
Committee’’ each quarter; that he submit
a practice plan to the Committee; that he
practice only ‘‘under the indirect
supervision’’ of a ‘‘monitoring
physician’’ approved by the Committee,
who is required to submit quarterly
reports to the Committee on
Respondent’s compliance and to
‘‘[r]eview 25 percent of [his] patient
records selected on a random basis at
least once each month’’ and who is also
required to report any violations of
applicable laws and regulations to the
Board. Id. at 1–5. Finally, the Board
prohibited Respondent ‘‘from writing
prescriptions for controlled substances
until such time as he is authorized to do
so by the * * * Probationer’s
Committee.’’ Id. at 5.
Respondent’s DEA Applications
On April 22, 2002, Respondent
submitted an application to renew his
DEA registration. In section 3 of the
application, Respondent was required to
answer four questions regarding
whether he had ever been convicted of
a controlled substance offense, and
whether sanctions had ever been
imposed against his DEA registration,
any state medical license, or any state
controlled substance registration.
More specifically, question 3(d)
asked: ‘‘Has the applicant ever
surrendered or had a state professional
license or controlled substance
registration revoked, suspended, denied,
restricted, or placed on probation? Is
any such action pending?’’ Respondent
circled ‘‘no.’’
On February 28, 2005, Respondent
submitted another application to renew
his registration. Respondent was
required to answer the same four
questions as on the previous
application. Once again, in answering
question 3(d), Respondent circled ‘‘no.’’
On January 31, 2008, Respondent
submitted another application to renew
his DEA registration. While there were
some minor changes to the application,
Respondent was required to answer the
same four questions as on the previous
applications. This time, however,
Respondent answered ‘‘yes’’ to the
question: ‘‘Has the applicant ever
surrendered (for cause) or had a state
professional license or controlled
substance registration revoked,
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
53963
suspended, denied, restricted, or placed
on probation, or is any such action
pending?’’ In the application’s block for
explaining the ‘‘nature of incident’’ and
the ‘‘result of incident,’’ Respondent
wrote ‘‘see attached.’’ Respondent
attached a copy of the Florida Board of
Medicine’s June 2007 Order on
Reinstatement and a letter to him from
a DOH Compliance Officer relating the
minutes of a September 7, 2007 meeting
of the Board’s Probation Committee. The
letter related that the Committee had
lifted the restriction on his prescribing
authority. Respondent did not, however,
disclose the two Georgia proceedings or
the 2003 Florida proceeding.
Discussion
Section 304(a)(1) of the Controlled
Substances Act (CSA) provides that a
registration ‘‘may be suspended or
revoked by the Attorney General upon
a finding that the registrant * * * has
materially falsified any application
pursuant to or required by this
subchapter.’’ 21 U.S.C. 824(a)(1).
Section 304(a)(4) also provides that a
registration to ‘‘dispense a controlled
substance * * * may be suspended or
revoked by the Attorney General upon
a finding that the registrant * * * has
committed such acts as would render
his registration under section 823 of this
title inconsistent with the public
interest as determined under such
section.’’ 21 U.S.C. 824(a)(4). With
respect to a practitioner, the CSA
requires that the following factors be
considered in making the public interest
determination:
(1) The recommendation of the appropriate
State licensing board or professional
disciplinary authority.
(2) The [registrant’s] experience in
dispensing * * * controlled substances.
(3) The [registrant’s] conviction record
under Federal or State laws relating to the
manufacture, distribution, or dispensing of
controlled substances.
(4) Compliance with applicable State,
Federal, or local laws relating to controlled
substances.
(5) Such other conduct which may threaten
the public health and safety.
21 U.S.C. 823(f).
‘‘[T]hese factors * * * are considered
in the disjunctive.’’ Robert A. Leslie, 68
FR 15227, 15230 (2003). I may rely on
any one or a combination of factors and
give each factor the weight I deem
appropriate in determining whether to
revoke an existing registration or to
deny an application to renew a
registration. Id. Moreover, I am ‘‘not
required to make findings as to all of the
factors.’’ Morall v. DEA, 412 F.3d 165,
173–74 (D.C. Cir. 2005); see also
E:\FR\FM\30AUN1.SGM
30AUN1
53964
Federal Register / Vol. 76, No. 168 / Tuesday, August 30, 2011 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
Volkman v. DEA, 567 F.3d 215, 222 (6th
Cir. 2009).
Having considered the evidence, I
conclude that the record establishes that
Respondent materially falsified his
2002, 2005, and 2008 applications for
DEA registrations. While there is
evidence suggesting that Respondent is
still abusing controlled substances, in
light of my conclusion with respect to
the material falsification allegations, I
deem it unnecessary to rule on the
Government’s alternative ground for
seeking the revocation of Respondent’s
registration.2
The Material Falsification Allegations
As found above, on both April 22,
2002 and February 28, 2005,
Respondent submitted an application to
renew his DEA registration on which he
answered ‘‘no’’ to the question: ‘‘Has the
applicant ever surrendered or had a
state professional license or controlled
substance registration revoked,
suspended, denied, restricted, or placed
on probation?’’ In both instances,
Respondent’s answer was false because
he failed to disclose (1) The Georgia
Board’s 1985 consent order which
placed him on probation for four years,
and (2) the Georgia Board’s 1990
Consent Order which suspended his
license. Moreover, Respondent’s
statement on his 2005 application was
false for the further reason that in 2003,
the Florida Board had imposed
restrictions on his license which
included that he remain in compliance
with the PRN contract and was
prohibited from writing controlled
substance prescriptions ‘‘for any family
member.’’
As for his January 31, 2008
application, it is true that Respondent
gave a ‘‘yes’’ answer to the question
regarding his state license and included
a copy of the Florida Board’s June 2007
reinstatement order. However, the
statement was still false because
Respondent failed to disclose the
Georgia Board’s 1985 and 1990 consent
orders, as well as the 2003 Florida
consent agreement.
It is likewise clear that Respondent’s
failure to disclose the various state
proceedings on each of the three
applications was a materially false
statement under the CSA. A false
statement is material if it ‘‘has a natural
tendency to influence, or was capable of
influencing, the decision of the
2 As found above, while the DOH 2006 complaint
makes the allegations that Respondent had admitted
to t relapse on crack cocaine and had been
diagnosed as being dependent on cocaine and
opioids, neither the Board’s Final Order nor the
Order on Reinstatement contain factual findings
establishing the validity of these allegations.
VerDate Mar<15>2010
20:31 Aug 29, 2011
Jkt 223001
decisionmaking body to which it was
addressed.’’ Kungys v. United States,
485 U.S. 759, 770 (1988) (int. quotation
and other citations omitted). While the
evidence must be ‘‘clear, unequivocal,
and convincing,’’ the ‘‘ultimate finding
of materiality turns on a substantive
interpretation of the law.’’ Id. at 772
(int. quotations and citations omitted).
See also Craig H. Bammer, 73 FR 34327,
34328 (2008).
Respondent’s false statements were
material because, under the public
interest standard, the Agency is required
to consider, inter alia, the applicant’s
experience in dispensing controlled
substances, his compliance with
applicable state and federal laws related
to controlled substances, and whether
his conduct threatens public health and
safety. See 21 U.S.C. 823(f). Disclosure
of each of the state orders would have
provided significant information to the
Agency showing that Respondent has a
significant problem with drug abuse;
DEA has long held that a practitioner’s
self-abuse of a controlled substance is a
relevant consideration under factor five
of the public interest standard and is
grounds for the revocation of an existing
registration or the denial of an
application for registration even where
there is no evidence that a practitioner
has abused his prescription-writing
authority.3 See Kenneth Wayne Green,
Jr., M.D., 59 FR 51453, 51454 (1994)
(registrant’s ‘‘continued drug usage and
relapses lead[ ] to the conclusion that
he cannot be entrusted with the
responsibilities of a DEA registrant and
that his continued possession of a
registration would be contrary to the
public interest’’); David E. Trawick, 53
FR 5326, 5327 (1988) (‘‘offenses or
wrongful acts committed by a registrant
outside of his professional practice, but
which relate to controlled substances
may constitute sufficient grounds for the
revocation of a’’ registration).
Disclosure of the 2003 Florida
proceeding (on the 2005 and 2008
applications) would have also provided
information that Respondent had been
accused of writing unlawful
prescriptions for hydrocodone, a
schedule III controlled substance. 21
CFR 1308.13(e). This information is
material to the Agency’s investigation
and assessment of Respondent’s
experience in dispensing controlled
substances and his compliance with
applicable laws related to the
dispensing of controlled
3 It is also relevant in assessing Respondent’s
compliance with applicable laws related to
controlled substances. See 21 U.S.C. 823(f)(4).
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
substances.4 See 21 U.S.C. 823(f)(2) &
(4).
I thus conclude that Respondent
materially falsified his 2002, 2005 and
2008 applications to renew his DEA
registration.5 Only one of these material
falsifications is necessary to support the
revocation of Respondent’s registration;
that there are three such instances
manifests a shocking level of dishonesty
on his part. 21 U.S.C. 824(a)(1).
Accordingly, Respondent’s registration
will be revoked and his pending
application will be denied.
Order
Pursuant to the authority vested in me
by 21 U.S.C. 823(f) & 824(a), as well as
28 CFR 0.100(b), I order that DEA
Certificate of Registration, BS4681979,
issued to Harold Edward Smith, M.D.,
be, and it hereby is, revoked. I further
order that the pending application of
Harold Edward Smith, M.D., to renew
his registration, be, and it hereby is,
denied. This Order is effective
September 29, 2011.
Dated: August 17, 2011.
Michele M. Leonhart,
Administrator.
[FR Doc. 2011–22090 Filed 8–29–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Dale J. Bingham, P.A.; Revocation of
Registration
On February 4, 2011, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, issued an Order to
Show Cause to Dale J. Bingham, P.A.
(Registrant), of Ash Fork, Arizona. The
Show Cause Order proposed the
revocation of Registrant’s DEA
Certificate of Registration MB1048746,
which authorizes him to dispense
controlled substances in schedules II
through V, as a mid-level practitioner,
on the ground that Registrant had
entered into a consent agreement with
the Arizona Regulatory Board of
Physician Assistants, pursuant to which
he no longer has ‘‘authority to handle
4 That the State did not require Respondent to
admit to the allegations in the consent agreement
does not make his failure to disclose the proceeding
any less material.
5 While the Agency did not grant Respondent’s
2008 application, ‘‘[i]t makes no difference that a
specific falsification did not exert influence so long
as it had the capacity to do so.’’ United States v.
Alemany Rivera, 781 F.2d 229, 234 (1st Cir. 1985).
Moreover, Respondent’s false statements on his
2002 and 2005 applications obviously did influence
the Agency’s decision to grant them.
E:\FR\FM\30AUN1.SGM
30AUN1
Agencies
[Federal Register Volume 76, Number 168 (Tuesday, August 30, 2011)]
[Notices]
[Pages 53961-53964]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-22090]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Harold Edward Smith, M.D.; Revocation Of Registration
On April 17, 2009, the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, issued an Order to
Show Cause to Harold Edward Smith, M.D. (Respondent), of Mt. Dora,
Florida. The Show Cause Order proposed the revocation of Respondent's
DEA Certificate of Registration, BS4681979, and the denial of any
pending applications to renew or modify the registration, on the
grounds that Respondent had materially falsified various applications
for his DEA registration and had committed acts which render his
registration inconsistent with the public interest. Show Cause Order at
1 (citing 21 U.S.C. 824(a)(1) & (4)).
The Show Cause Order alleged that Respondent has ``a documented
substance abuse history dating back as far as 1982,'' when he ``entered
treatment for alcohol and controlled substance abuse.'' Id. The Order
alleged that on April 3, 1985, Respondent entered into a consent order
with the Georgia Board of Medical Examiners (Georgia Board) based on
his ``chemical dependency,'' which placed him on probation for four
years and imposed various conditions including that he ``abstain from
the consumption of alcohol or controlled substances,'' undergo random
drug testing, and ``relinquish'' his controlled substance privileges.
Id. The Order then alleged that in June 1990, Respondent tested
positive for cocaine and that on October 10, 1990, he ``entered into an
Interim Consent Order'' with the Georgia Board under which his medical
license was suspended and he was ordered (1) Not to practice medicine,
(2) not to use his DEA registration, and (3) ``to participate in a
program for impaired physicians.'' Id. at 2.
Next, the Show Cause Order alleged that during 1999 and 2000,
Respondent issued prescriptions for hydrocodone to J.R.S. and L.L.S.,
and had failed to maintain the ``records of any examinations,
diagnoses, treatment[s] or * * * drugs prescribed to these individuals
as required by Section 458.331(1)(q) of the Florida statutes.'' Id. The
Order further alleged that based on this conduct, Respondent ``entered
into a Consent Agreement with the'' Florida Board of Medicine, which
required him to pay a fine of $5,000, desist ``from prescribing to
family members'' and to
[[Page 53962]]
take ``a course on the proper prescribing of [a]busable [d]rugs.'' Id.
(int. quotations omitted).
The Show Cause Order further alleged that on February 16, 2007, the
Florida Board indefinitely suspended Respondent's medical license
``based in part'' on his ``admission of'' having ``relapse[d] on crack
cocaine'' and ``failure to submit to a urine screen while under
contract with the Board's impaired physicians' program.'' Id. The Order
then alleged that on June 26, 2007, the Florida Board reinstated
Respondent's medical license ``subject to several probationary terms.''
Id.
Finally, the Show Cause Order alleged that ``[o]n April 22, 2002,
February 28, 2005, and again on January 31, 2008,'' Respondent had
``submitted applications for renewal'' of his DEA registration. Id. The
Order alleged that each of these applications was materially false
because Respondent failed to disclose the various sanctions imposed on
his state licenses by the Georgia and Florida Boards, as well as the
previous ``surrenders'' of his DEA registration. Id.
On May 8, 2009, the Show Cause Order, which also notified
Respondent of his right to request a hearing on the allegations (or to
submit a written statement in lieu of a hearing) and the consequences
if he failed to do so, Id. at 2, was served on Respondent by certified
mail to him at the address given on his most recent application as his
registered location. Since that date, neither Respondent, nor any
person purporting to represent him, has filed a request for a hearing
or submitted a written statement in lieu of a hearing. As thirty days
have now passed since Respondent was served with the Order to Show
Cause, I find that Respondent has waived his right to a hearing. See 21
CFR 1301.43(d). I therefore enter this Final Order without a hearing
based on relevant evidence contained in the Investigative Record. See
Id. at 1301.43(e). I make the following findings.
Findings
Respondent currently holds DEA Certificate of Registration
BS4681979, which authorizes him to dispense controlled substances in
schedules II through V as a practitioner, at the registered address of
2875 S. Orange Ave., Suite 500-600, Orlando, Florida. While
Respondent's registration was to expire on February 29, 2008, on
February 7, 2008, he submitted an application to renew his
registration. In accordance with the Administrative Procedure Act,
Respondent's registration remains in effect pending the issuance of
this Final Order. See 5 U.S.C. 558(c).
The State Proceedings Against Respondent
In April 1983, Respondent, who was then licensed in Arkansas and
Tennessee, was discharged from an impaired physicians program.
Thereafter, Respondent applied for a Georgia medical license. On April
17, 1985, Respondent entered into a Consent Order with the Georgia
Board, which noted that he had ``completed a treatment program for
chemical dependency.'' Consent Order at 1, In re Harold Edward Smith,
Jr., M.D., No. 91328-85 (Ga. Bd. Med. Exam'rs, April 17, 1985).
Pursuant to the Consent Order, the Georgia Board issued Respondent a
medical license and placed him on probation for four years subject to
several conditions. Id. at 2-4. The conditions included that he
``completely abstain from the consumption of alcohol or controlled
substances, except as prescribed by a duly licensed practitioner for a
legitimate purpose,'' that he ``undergo random alcohol/drug screening
at his own expense,'' that he ``not possess a DEA permit or any
triplicate prescription forms or Federal order forms,'' and that he
relinquish his right (until further order by the Board) ``to prescribe,
administer, dispense, order or possess (except as prescribed,
administered or dispensed to [him] by another person authorized by law
to do so) controlled substances.'' Id. Respondent was also required to
``submit quarterly reports regarding his physical and mental condition
to the Board * * * including a report on any medication being
prescribed to'' him. Id. at 3. In April 1989, Respondent was
``discharged from probation.'' Interim Consent Order for Suspension of
License During Treatment at 1, In re Harold Edward Smith, Jr., M.D.,
No. 90-499 (Ga. Bd. Med. Exam'rs, Oct. 10, 1990).
In June 1990, physicians at Respondent's place of employment
requested that he provide a specimen for drug testing. Id. at 2. The
specimen tested positive for cocaine. Id. Subsequently, the Georgia
Board ordered Respondent to ``undergo a 72-hour inpatient mental/
physical examination evaluation'' and thereafter, Respondent entered
``treatment for relapse of chemical dependence.'' Id.
On October 10, 1990, Respondent entered into an Interim Consent
Order with the Georgia Board pursuant to which he agreed that his
license would be ``suspended until further order of the board''; that
during the suspension, he would ``not engage in the practice of
medicine or be authorized to utilize his DEA registration for
controlled substances''; and that he would not resume practicing
medicine or use his DEA registration ``without the prior written
approval of the Board.'' Id. at 3 & 8. Respondent also agreed to
``remain in treatment,'' to ``abide by all conditions of his treatment/
aftercare program,'' and to submit ``quarterly reports on his mental/
physical condition and progress in rehabilitation.'' Id. at 3.
Moreover, as a condition of the Board's lifting of the suspension
(after he completed treatment and executed an aftercare contract),
Respondent was required to submit: (1) A certification by his
monitoring physicians that he had ``successfully completed treatment''
and ``is able to resume the practice of medicine with reasonable skill
and safety,'' (2) a plan to return to practice under a ``physician who
would actively supervise [his] practice,'' and (3) ``a summary of
continuing education activity in the last year.'' Id. at 4-5.
At some point, Respondent moved to Florida and obtained a medical
license from the Florida Department of Health (DOH). On October 18,
2002, the DOH filed an Administrative Complaint against him. See
Administrative Complaint, Department of Health v. Smith, No. 2000-12434
(Fla. DOH). The Complaint alleged that ``[f]rom on or about July 24,
1999 to on or about August 14, 2000,'' Respondent wrote hydrocodone
prescriptions for J.R.S., and that ``[f]rom on or about January 14,
2000 to on or about June 30, 2000,'' Respondent wrote hydrocodone
prescription for L.L.S., both of whom were alleged to be related to
him. Id. at 2. The Complaint further alleged that Respondent ``did not
keep records of [his] examinations, diagnoses, treatment or * * * drugs
prescribed'' for either person. Id.
On June 18, 2003, Respondent entered into a Consent Agreement with
the DOH. Consent Agreement at 6-7. Therein, Respondent neither admitted
nor denied the allegations. Id. at 2. However, he agreed to pay a fine
of $2,000, to reimburse the DOH for its costs in the amount of
$4,776.58, and to complete a course entitled ``Protecting Your Medical
Practice, Clinical, Legal and Ethical Issues in Prescribing Abusable
Drugs.\1\ '' Id. at 2-4.
---------------------------------------------------------------------------
\1\ The Order further noted that ``[t]he terminal condition of
Respondent's mother understandably contributed to poor judgment for
the time he provided prescriptions for her.'' Consent Agreement at
4.
---------------------------------------------------------------------------
On August 18, 2003, the Florida Board of Medicine rejected the
Consent
[[Page 53963]]
Agreement and offered a counter agreement, which the parties accepted.
Final Order at 1. The Agreement increased the fine to $5,000, imposed a
restriction on his license requiring him to ``remain in compliance with
any and all terms of'' his contract with the Professional Resource
Network (PRN), and prohibited him ``from writing prescriptions for
controlled substances for any family member.'' Id. at 1-2.
On May 31, 2006, the DOH filed another Administrative Complaint
against Respondent. Administrative Complaint, Department of Health v.
Harold Smith, M.D., No. 2005-67946. The Complaint alleged that on
approximately August 9, 2005, Respondent had ceased complying with his
PRN contract and that, on August 16, 2005, a PRN monitor had contact
with him and ``recommended,'' based on his ``body language and general
demeanor[,] * * * that [he] undergo a psychiatric evaluation.'' Id. at
4-5. PRN then allegedly ``requested that Respondent submit to a
psychiatric evaluation and drug screen''; however, Respondent failed to
``present for his drug screen.'' Id. at 5. The Complaint further
alleged that three weeks later, ``Respondent contacted PRN and admitted
to a relapse on crack cocaine and agreed to be evaluated.'' Id.
The Complaint alleged that on or about October 7, 2005, Respondent
was evaluated and ``diagnosed with cocaine dependence'' and ``opioid
dependence, in apparent relapse.'' Id. The Complaint further alleged
that the evaluator found that ``Respondent was not safe to practice
medicine'' and recommended that he enter a ``structured detoxification
and stabilization unit and undergo intensive psychotherapy.'' Id. at 5-
6. The Complaint alleged that while Respondent completed this portion
of his treatment, he subsequently refused to enter into a halfway
house, did not have a phone, and had no money to pay for urine screens.
Id. at 6. The State thus alleged that Respondent was ``unable to
practice medicine with reasonable skill and safety to patients due to
his substance abuse problems and his unwillingness to undergo
additional treatment'' and monitoring by PRN. Id. at 7.
In February 2007, the Florida Board of Medicine issued a Final
Order adopting a settlement agreement which Respondent had entered into
with the State. Final Order at 2, DOH v. Harold Smith, M.D., No. 2005-
67946 (Fla. Bd. Med., Feb. 15, 2007). Apparently (as the agreement is
not part of the record), Respondent had agreed to the suspension of his
medical license. See Order on Reinstatement, DOH v. Harold Smith, M.D.,
No. 2005-67946 (Fla. Bd. Med., June 26, 2007).
On June 26, 2007, the Board reinstated Respondent's license and
placed him ``on probation for a period to run concurrent with his [PRN]
contract.'' Id. at 1. The Board imposed the following conditions: That
he comply with his PRN contract; that he appear before the Board's
``Probationer's Committee'' each quarter; that he submit a practice
plan to the Committee; that he practice only ``under the indirect
supervision'' of a ``monitoring physician'' approved by the Committee,
who is required to submit quarterly reports to the Committee on
Respondent's compliance and to ``[r]eview 25 percent of [his] patient
records selected on a random basis at least once each month'' and who
is also required to report any violations of applicable laws and
regulations to the Board. Id. at 1-5. Finally, the Board prohibited
Respondent ``from writing prescriptions for controlled substances until
such time as he is authorized to do so by the * * * Probationer's
Committee.'' Id. at 5.
Respondent's DEA Applications
On April 22, 2002, Respondent submitted an application to renew his
DEA registration. In section 3 of the application, Respondent was
required to answer four questions regarding whether he had ever been
convicted of a controlled substance offense, and whether sanctions had
ever been imposed against his DEA registration, any state medical
license, or any state controlled substance registration.
More specifically, question 3(d) asked: ``Has the applicant ever
surrendered or had a state professional license or controlled substance
registration revoked, suspended, denied, restricted, or placed on
probation? Is any such action pending?'' Respondent circled ``no.''
On February 28, 2005, Respondent submitted another application to
renew his registration. Respondent was required to answer the same four
questions as on the previous application. Once again, in answering
question 3(d), Respondent circled ``no.''
On January 31, 2008, Respondent submitted another application to
renew his DEA registration. While there were some minor changes to the
application, Respondent was required to answer the same four questions
as on the previous applications. This time, however, Respondent
answered ``yes'' to the question: ``Has the applicant ever surrendered
(for cause) or had a state professional license or controlled substance
registration revoked, suspended, denied, restricted, or placed on
probation, or is any such action pending?'' In the application's block
for explaining the ``nature of incident'' and the ``result of
incident,'' Respondent wrote ``see attached.'' Respondent attached a
copy of the Florida Board of Medicine's June 2007 Order on
Reinstatement and a letter to him from a DOH Compliance Officer
relating the minutes of a September 7, 2007 meeting of the Board's
Probation Committee. The letter related that the Committee had lifted
the restriction on his prescribing authority. Respondent did not,
however, disclose the two Georgia proceedings or the 2003 Florida
proceeding.
Discussion
Section 304(a)(1) of the Controlled Substances Act (CSA) provides
that a registration ``may be suspended or revoked by the Attorney
General upon a finding that the registrant * * * has materially
falsified any application pursuant to or required by this subchapter.''
21 U.S.C. 824(a)(1). Section 304(a)(4) also provides that a
registration to ``dispense a controlled substance * * * may be
suspended or revoked by the Attorney General upon a finding that the
registrant * * * has committed such acts as would render his
registration under section 823 of this title inconsistent with the
public interest as determined under such section.'' 21 U.S.C.
824(a)(4). With respect to a practitioner, the CSA requires that the
following factors be considered in making the public interest
determination:
(1) The recommendation of the appropriate State licensing board
or professional disciplinary authority.
(2) The [registrant's] experience in dispensing * * * controlled
substances.
(3) The [registrant's] conviction record under Federal or State
laws relating to the manufacture, distribution, or dispensing of
controlled substances.
(4) Compliance with applicable State, Federal, or local laws
relating to controlled substances.
(5) Such other conduct which may threaten the public health and
safety.
21 U.S.C. 823(f).
``[T]hese factors * * * are considered in the disjunctive.'' Robert
A. Leslie, 68 FR 15227, 15230 (2003). I may rely on any one or a
combination of factors and give each factor the weight I deem
appropriate in determining whether to revoke an existing registration
or to deny an application to renew a registration. Id. Moreover, I am
``not required to make findings as to all of the factors.'' Morall v.
DEA, 412 F.3d 165, 173-74 (D.C. Cir. 2005); see also
[[Page 53964]]
Volkman v. DEA, 567 F.3d 215, 222 (6th Cir. 2009).
Having considered the evidence, I conclude that the record
establishes that Respondent materially falsified his 2002, 2005, and
2008 applications for DEA registrations. While there is evidence
suggesting that Respondent is still abusing controlled substances, in
light of my conclusion with respect to the material falsification
allegations, I deem it unnecessary to rule on the Government's
alternative ground for seeking the revocation of Respondent's
registration.\2\
---------------------------------------------------------------------------
\2\ As found above, while the DOH 2006 complaint makes the
allegations that Respondent had admitted to t relapse on crack
cocaine and had been diagnosed as being dependent on cocaine and
opioids, neither the Board's Final Order nor the Order on
Reinstatement contain factual findings establishing the validity of
these allegations.
---------------------------------------------------------------------------
The Material Falsification Allegations
As found above, on both April 22, 2002 and February 28, 2005,
Respondent submitted an application to renew his DEA registration on
which he answered ``no'' to the question: ``Has the applicant ever
surrendered or had a state professional license or controlled substance
registration revoked, suspended, denied, restricted, or placed on
probation?'' In both instances, Respondent's answer was false because
he failed to disclose (1) The Georgia Board's 1985 consent order which
placed him on probation for four years, and (2) the Georgia Board's
1990 Consent Order which suspended his license. Moreover, Respondent's
statement on his 2005 application was false for the further reason that
in 2003, the Florida Board had imposed restrictions on his license
which included that he remain in compliance with the PRN contract and
was prohibited from writing controlled substance prescriptions ``for
any family member.''
As for his January 31, 2008 application, it is true that Respondent
gave a ``yes'' answer to the question regarding his state license and
included a copy of the Florida Board's June 2007 reinstatement order.
However, the statement was still false because Respondent failed to
disclose the Georgia Board's 1985 and 1990 consent orders, as well as
the 2003 Florida consent agreement.
It is likewise clear that Respondent's failure to disclose the
various state proceedings on each of the three applications was a
materially false statement under the CSA. A false statement is material
if it ``has a natural tendency to influence, or was capable of
influencing, the decision of the decisionmaking body to which it was
addressed.'' Kungys v. United States, 485 U.S. 759, 770 (1988) (int.
quotation and other citations omitted). While the evidence must be
``clear, unequivocal, and convincing,'' the ``ultimate finding of
materiality turns on a substantive interpretation of the law.'' Id. at
772 (int. quotations and citations omitted). See also Craig H. Bammer,
73 FR 34327, 34328 (2008).
Respondent's false statements were material because, under the
public interest standard, the Agency is required to consider, inter
alia, the applicant's experience in dispensing controlled substances,
his compliance with applicable state and federal laws related to
controlled substances, and whether his conduct threatens public health
and safety. See 21 U.S.C. 823(f). Disclosure of each of the state
orders would have provided significant information to the Agency
showing that Respondent has a significant problem with drug abuse; DEA
has long held that a practitioner's self-abuse of a controlled
substance is a relevant consideration under factor five of the public
interest standard and is grounds for the revocation of an existing
registration or the denial of an application for registration even
where there is no evidence that a practitioner has abused his
prescription-writing authority.\3\ See Kenneth Wayne Green, Jr., M.D.,
59 FR 51453, 51454 (1994) (registrant's ``continued drug usage and
relapses lead[ ] to the conclusion that he cannot be entrusted with the
responsibilities of a DEA registrant and that his continued possession
of a registration would be contrary to the public interest''); David E.
Trawick, 53 FR 5326, 5327 (1988) (``offenses or wrongful acts committed
by a registrant outside of his professional practice, but which relate
to controlled substances may constitute sufficient grounds for the
revocation of a'' registration).
---------------------------------------------------------------------------
\3\ It is also relevant in assessing Respondent's compliance
with applicable laws related to controlled substances. See 21 U.S.C.
823(f)(4).
---------------------------------------------------------------------------
Disclosure of the 2003 Florida proceeding (on the 2005 and 2008
applications) would have also provided information that Respondent had
been accused of writing unlawful prescriptions for hydrocodone, a
schedule III controlled substance. 21 CFR 1308.13(e). This information
is material to the Agency's investigation and assessment of
Respondent's experience in dispensing controlled substances and his
compliance with applicable laws related to the dispensing of controlled
substances.\4\ See 21 U.S.C. 823(f)(2) & (4).
---------------------------------------------------------------------------
\4\ That the State did not require Respondent to admit to the
allegations in the consent agreement does not make his failure to
disclose the proceeding any less material.
---------------------------------------------------------------------------
I thus conclude that Respondent materially falsified his 2002, 2005
and 2008 applications to renew his DEA registration.\5\ Only one of
these material falsifications is necessary to support the revocation of
Respondent's registration; that there are three such instances
manifests a shocking level of dishonesty on his part. 21 U.S.C.
824(a)(1). Accordingly, Respondent's registration will be revoked and
his pending application will be denied.
---------------------------------------------------------------------------
\5\ While the Agency did not grant Respondent's 2008
application, ``[i]t makes no difference that a specific
falsification did not exert influence so long as it had the capacity
to do so.'' United States v. Alemany Rivera, 781 F.2d 229, 234 (1st
Cir. 1985). Moreover, Respondent's false statements on his 2002 and
2005 applications obviously did influence the Agency's decision to
grant them.
---------------------------------------------------------------------------
Order
Pursuant to the authority vested in me by 21 U.S.C. 823(f) &
824(a), as well as 28 CFR 0.100(b), I order that DEA Certificate of
Registration, BS4681979, issued to Harold Edward Smith, M.D., be, and
it hereby is, revoked. I further order that the pending application of
Harold Edward Smith, M.D., to renew his registration, be, and it hereby
is, denied. This Order is effective September 29, 2011.
Dated: August 17, 2011.
Michele M. Leonhart,
Administrator.
[FR Doc. 2011-22090 Filed 8-29-11; 8:45 am]
BILLING CODE 4410-09-P